HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Featured Stories


Second Time Lucky? Sumatriptan One Of Three Switches On The Cards In Germany

A second attempt at switching sumatriptan for migraines, as well as switch applications for non-steroidal anti-inflammatories ketoprofen and liquid ibuprofen, are all on the agenda at Germany's next Expert Committee for Prescription meeting in June. 

Health OTC Drugs Prescription To Otc Switch

CBD Supplement Market Enforcement Based On FDA Concerns, Not Discretion

Although agency is prioritizing enforcement on hemp and CBD supplement and food products marketed with violative claims and allowing sales of products compliant with its regulations, the approach is not enforcement discretion, officials say. It's aware some companies are marketing hemp and CBD products "in ways that violate the law," and its "biggest concern" is products "that put the health and safety of consumers at greatest risk."

Dietary Supplements FDA Compliance

E.l.f. Shutters Its Stores, Ratchets Up Digital Marketing To Reinvigorate Brand’s ‘Superpowers’

The Oakland, Calif.-based firm is cautiously projecting net sales declines of 4% to 8% in fiscal 2020, but is confident about its strategic redirection, which prioritizes packaging redesigns, first-to-mass items and “fewer, bolder product stories” under new marketing leadership brought on board in February from Shiseido.

Beauty Sales & Earnings Business Strategies

Private-Equity Investors Poised To Acquire Nestlé Skin Health, Promising US Expansion

After working hard to turnaround its troubled Skin Health dermatology operation, Nestlé looks set to offload the business to a consortium of private-equity buyers. The consortium - led by EQT - have identified expansion in the US consumer health market as an immediate priority.
Deals OTC Drugs Cosmetics
Advertisement

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.

 

The 2019 OTC Marketing Awards

Co-presented by IRI – The 2019 OTC Marketing Awards celebrated the best and brightest of the UK consumer healthcare sector and clearly demonstrated that the industry is in rude health. Read this eBook to learn more.

Read more
Advertisement

Health Explore this Topic

Set Alert for Health

Latest From Health

Can You Kick It? Yes You Can, With Six New Foot-Care Products In The UK

New OTC medicines for fungal nail infections and verrucas have been launched in the UK by Galderma, Reckitt Benckiser and Vemedia, while new foot-care products have also been introduced by Blistex, Epitact and Dermatonics.

OTC Drugs Launches

GSK Admits Voltaren Marketing Misled Australian Consumers, Now Facing Financial Penalty

GSK has admitted misleading Australian consumers with the marketing of its Voltaren range by claiming Osteo Gel was specifically formulated for treating osteoarthritis conditions, and was more effective than Emulgel to treat those conditions, when the two products were identically formulated. While a change to Osteo Gel's packaging has since satisfied Australia's Federal Court, GSK is still facing a financial penalty for its earlier conduct.
Legal Issues Ad Campaigns

Health And Wellness Products Trademark Review May 14, 2019

Trademarks registered and published for opposition with USPTO in Class 3 – cosmetics and cleaning Preps, and Class 5 –pharmaceuticals. Marks for vitamin, mineral and supplement products also are registered or published for opposition in both Class 3 and Class 5.
OTC Drugs Dietary Supplements

Unreliable Survey Doesn't Sink Mucinex Fast-Max 'All In One' Claim In NAD Review

RB didn't get help from consumer perception survey to support argument that "All In One" label statement is not claim the product treats all cold and flu symptoms. Council of Better Business Bureaus' division dismisses survey as faulty but approves RB's argument. NAD attorneys conclude 15- and 6-second TV and video "superhero 'movie trailer'” ads did not include "a sufficiently proximate and prominent list of symptoms" to counter "distracting features."

OTC Drugs Ad Campaigns

Japan's Taisho Suffers Declines At Home And Abroad As It Ends Disappointing Year

With sales falling across the board in 2018, Taisho is counting on acquisitions overseas and new organic growth initiatives at home to turn the tide.
Sales & Earnings OTC Drugs

No Relief For TummyZen Heartburn Claims In Industry-Self Regulation Forum

Eli Nutrition fails in appeal of NAD review of claims for its TummyZen heartburn relief product, with a panel of the National Advertising Review Board concluding the firm overstated its product’s benefits.

OTC Drugs Dietary Supplements
See All

Beauty Explore this Topic

Set Alert for Beauty

Latest From Beauty

Cosmetics Weekly Trademark Review: May 21, 2019

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.
United States Beauty

CBD Cosmetics Rush Is ‘Fast And Furious,’ But Don’t Skimp On Testing, Experts Say

Speakers at ICMAD’s regulatory workshop in New York stressed the importance of CBD testing in today’s highly uncertain climate for hemp-based cosmetics. While rigorous testing can drive up costs and slow the path to market, it also could significantly reduce chances of safety, regulatory or legal issues down the line.

Beauty Cosmetic Ingredients

Cosmetic CBD Has Insurance Industry Spooked: The Dope Before You Toke

Marketing CBD-containing cosmetics in today’s hazy legal and regulatory environment carries risks beyond what insurance carriers may be willing to take on. Kenneth Hegel of Cosmetic Insurance Services, a division of brokerage firm Frenkel & Company – an Epic Company, discusses the dilemma facing underwriters and criteria companies can meet to improve their insurance prospects.

Beauty Cosmetic Ingredients

Cosmetics Weekly Trademark Review: May 14, 2019

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.
United States Beauty

Interested In Using CBD Or Probiotics In Cosmetics? Ask Yourself Why – FDA’s Linda Katz

The answer to the ‘why’ question can help clarify whether a company is marketing a cosmetic or an unapproved drug, FDA’s cosmetics office director advised attendees at ICMAD’s 38th annual regulatory workshop in New York.

Beauty Cosmetic Ingredients

FDA Final MUsT Guidance For Topical OTCs Bolstered By Agency's Recent Study Results

FDA final guidance on MUsTs for topically applied ingredients for OTC drug monograph affirms draft, not incorporating changes pushed by industry. CHPA says FDA’s MUsT study published recently finding sunscreen actives penetrate skin to bloodstream at higher levels than previously believed demonstrates "value" of test method.

OTC Drugs FDA
See All

Wellness Explore this Topic

Set Alert for Wellness

Latest From Wellness

Before Asking FDA For Novel OTC Switch, Be Sure DFL Alone 'Can't Get There'

"You need to demonstrate to the best of your ability that you can't get there with just the Drug Facts label," says ONDP Director Theresa Michele during presentation on the FDA office' work over the past year at Consumer Healthcare Products Association's annual regulations and science conference.

Prescription To Otc Switch OTC Drugs

Legalizing Marijuana Would Calm CBD Regulatory Storm – CV Science's MacKay

As FDA moves slow on allowing CBD as a dietary ingredient, a marijuana reform law is a near-term possibility and would cause a “nuclear shift” about cannabis regulation and sway agency's decision, says cannabidiol firm CV Sciences executive.

Dietary Supplements FDA

GMO Evolution Creates Challenges For ‘Clean Label’ Supplement Marketers

Supplement and food firms should "check to see if any ingredients they use may be affected or potentially contaminated by genetically engineered bio-synthesized ingredients,” said Jim Thomas, scientist and co-founder of ETC Group. Biotechnologies have emerged to yield ingredients for clean label products with organisms raised in ecosystems developed from processes that involve genetic engineering.

Dietary Supplements Business Strategies

'Innovation' Meeting Shows FDA-Industry Gap On NDI Guidance Details Remains

Panel discussions and public comments during FDA public meeting show industry sees agency, as it stated in draft NDI notification guidances published in 2011 and 2016, is allowing little room for innovation through making new ingredients available for use in VMS products. FDA says immense growth of the VMS market since DSHEA passed shows numerous products available in US contain substances that haven't been notified to the FDA with proof showing they are dietary ingredients and are safe for use.

Dietary Supplements FDA

Degree Of Difficulty Could Climb For Industry's NDI Investments To Continue

"Can we maybe as an industry, and I guess the FDA, agree not to overcomplicate the NDI process in the sense that it's actually pretty easy to navigate the process and understand what you have," says Frank Jaksch, Chromadex co-founder and executive chairman. "I want to encourage companies to do the right thing," says Mark LeDoux, founder, CEO and chairman of Natural Alternatives Internationa. "Our firm spent millions of dollars and went through the front door of the FDA. … This is not a difficult process to do the right thing."

Dietary Supplements Regulation

Turmeric Supplements Linked To Cases Of Hepatitis By Italy’s National Institute Of Health

Italy's National Institute of Health is warning consumers not to take certain turmeric-based supplements after receiving in the past 10 days a handful of reports linking the consumption of products marketed by local firm NI.VA to cases of hepatitis. 
Europe Italy
See All

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

The Dutch OTC Market In 2018: Pharmacists Not Consumer Friendly, Supermarkets Capitalize

While the Dutch OTC market grew steadily by 3.2% to €753m in 2018, according to IQVIA data, the country's self-care industry association, Neprofarm, pointed to a changing retail landscape in the Netherlands where supermarkets are grabbing market share from pharmacies. 
Health OTC Drugs

Consumer Reports Issues 2019 Sunscreen Recommendations; All Contain Oxybenzone

While acknowledging concerns about oxybenzone, Consumer Reports maintains the importance of sunscreen to help prevent skin cancer and says oxybenzone-containing offerings continue to test best when it comes to broad-spectrum protection and minimal SPF “variation.”

Beauty Health

Germany's Wellness Market 2018: Online, Vitamins and Probiotics Drive Growth

Germany's market for wellness products grew by 6.5% to €2.08bn in 2018, driven by the country's online sales channel, strong sales of vitamin and mineral supplements and a continuing interest in probiotics for digestive health, according to data from market researcher IQVIA.
Wellness Dietary Supplements
See All
UsernamePublicRestriction

Register

Advertisement